INITIAL STEP OF ASSESSING THE RESULT OF FOLAT TREATMENT IN RECURRENT PREGNANCY LOSS PATIENTS CARRYING THE MTHFR MUTATED GENE
Main Article Content
Abstract
Recurrent pregnancy loss (RPL) and gene MTHFR polymorphism have been found to be strongly associated in Asian people. Folate treatment is believed to reduce blood homocysteine levels and improve pregnancy outcomes. Objective: the study aims to evaluate the results of folate treatment in patients carrying the MTHFR C677T polymorphism at Hanoi Obstetrics and Gynecology Hospital. A cross-sectional study of 30 patients with a history of RPL and MTHFR mutation was treated with 5 mg folate/day during 3 months. Results 100% of patients carried the CT heterozygous MTHFR gene. The average concentration of homocysteine before and after treatment was 10.3±3.47; 6.8±2.48 µmol/l respectively, (p=0,000). Conclusion: Folate treatment during 3 months reduces homocysteine levels in the blood.
Article Details
Keywords
recurrent pregnancy loss, MTHFR, methyl folat
References
2. Lê Thị Anh Đào, Nghiên cứu hội chứng kháng phospholipid ở thai phụ có tiền sử sẩy thai liên tiếp đến 12 tuần. 2016, Đại học Y Hà Nội.
3. Serapinas D; Boreikaite E; Bartkeviciute A; et al, The importance ò folate, vitamins B6 and b12 for the lowering of homocysteine concentrations for patients with recurrent.
4. Ganji, V. and M.R. Kafai, Demographic, life: and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. J Nutr, 2009. 139(2); p.345-52.